Of the 81 GFAP-IgG-positive patients, 16 patients with AQP4-IgG or MOG-IgG were classified into the overlapping syndrome group, while 65 patients without AQP4-IgG or MOG-IgG were classified into the nonoverlapping syndrome group. The gene discussed is AQP4; the disease is Down syndrome.